NCT02277678

Brief Summary

The primary objectives of this study are to compare the efficacy of pain relief between epidural oxycodone and epidural morphine for postoperative analgesia after elective caesarean section and to compare the incidence and severity of pruritus. Secondary objectives are to compare other side effects of epidural administered oxycodone and morphine (nausea and vomiting, sedation, respiratory depression) and to investigate the safety and efficacy of epidural oxycodone and epidural morphine after use for postoperative analgesia in caesarean sections.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2013

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

October 26, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 29, 2014

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

September 4, 2015

Status Verified

September 1, 2015

Enrollment Period

1.3 years

First QC Date

October 26, 2014

Last Update Submit

September 3, 2015

Conditions

Keywords

Pruritus

Outcome Measures

Primary Outcomes (1)

  • Pruritus

    Incidence of pruritus at 24 hours

    1 day

Secondary Outcomes (2)

  • Pain

    1 day

  • Nausea and Vomiting

    1 day

Study Arms (2)

Oxycodone

EXPERIMENTAL

Epidural oxycodone 3mg single dose as opioid administration

Drug: Opioid administration oxycodone

Morphine

ACTIVE COMPARATOR

Epidural morphine 3mg single dose as opioid administration

Drug: Opioid administration morphine

Interventions

Epidural administration single dose through epidural catheter

Also known as: Epidural Opioid
Oxycodone

Eligibility Criteria

Age21 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status 1-2,
  • aged between 21 to 50 years undergoing a term elective caesarean section and
  • had consented for combined spinal-epidural (CSE) anaesthesia

You may not qualify if:

  • concurrent opioid therapy,
  • contraindications to CSE anaesthesia or any of the study medications,
  • a history of pre-existing nausea and vomiting,
  • failure to identify intrathecal space at time of anaesthesia,
  • inadvertent dural puncture with the epidural needle and
  • conversion of regional anaesthesia to general anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KK Women's and Children's Hospital

Singapore, Singapore, 229899, Singapore

Location

MeSH Terms

Conditions

Pruritus

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesSkin ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ban L Sng, FANZCA

    KK Women's and Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2014

First Posted

October 29, 2014

Study Start

August 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

September 4, 2015

Record last verified: 2015-09

Locations